Literature DB >> 7771838

Systemic blood activation with open and closed venous reservoirs.

J P Schönberger1, P A Everts, J J Hoffmann.   

Abstract

In 20 patients undergoing coronary artery bypass grafting, we studied prospectively systemic blood activation, blood loss, and the need for donor blood when using an extracorporeal circuit equipped at random with one of two different venous reservoirs. In 10 patients we used an open venous reservoir system (ORS) consisting of a hard shell venous reservoir with an integral cardiotomy filter, and in 10 patients we used a closed reservoir system consisting of a collapsible venous reservoir and separate cardiotomy reservoir. Concentrations of complement 3a, elastase, thromboxane B2, and fibrin degradation products showed a biphasic course, especially in ORS patients. During bypass, we observed a first peak of levels of complement 3a, thromboxane B2, fibrin degradation products, and elastase, which was higher in ORS patients than in patients with the closed system, because their blood continuously contacted the foreign materials of the filter and air in the open reservoir, which was avoided in the closed reservoir. Intensive blood-foreign material contact also caused the highest (p < 0.05) hemolysis in ORS patients. The larger amount of hemolytic products in ORS patients theoretically resulted in a temporary decrease in capacity of their Kupffer cells to clear endotoxin released after aortic declamping. This theory might explain the significantly (p < 0.01) higher second peak of activated products after declamping that was observed in ORS patients. Due to increased blood activation, the largest (p < 0.001) amount of shed blood loss, greatest (p < 0.05) need for colloid-crystalloid infusion, and largest (not significant) need for donor blood were found in ORS patients (0.8 +/- 0.4 versus 0.2 +/- 0.2 units of packed cells).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771838     DOI: 10.1016/0003-4975(95)00241-c

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Microbubble generation and transmission of medtronic's affinity hardshell venous reservoir and collapsible venous reservoir bag: an in-vitro comparison.

Authors:  Kieron C Potger; Darryl McMillan; Mark Ambrose
Journal:  J Extra Corpor Technol       Date:  2011-09

Review 2.  Use of minimal invasive extracorporeal circulation in cardiac surgery: principles, definitions and potential benefits. A position paper from the Minimal invasive Extra-Corporeal Technologies international Society (MiECTiS).

Authors:  Kyriakos Anastasiadis; John Murkin; Polychronis Antonitsis; Adrian Bauer; Marco Ranucci; Erich Gygax; Jan Schaarschmidt; Yves Fromes; Alois Philipp; Balthasar Eberle; Prakash Punjabi; Helena Argiriadou; Alexander Kadner; Hansjoerg Jenni; Guenter Albrecht; Wim van Boven; Andreas Liebold; Fillip de Somer; Harald Hausmann; Apostolos Deliopoulos; Aschraf El-Essawi; Valerio Mazzei; Fausto Biancari; Adam Fernandez; Patrick Weerwind; Thomas Puehler; Cyril Serrick; Frans Waanders; Serdar Gunaydin; Sunil Ohri; Jan Gummert; Gianni Angelini; Volkmar Falk; Thierry Carrel
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-01-26

3.  Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting.

Authors:  Toshihiro Ohata; Masataka Mitsuno; Mitsuhiro Yamamura; Hiroe Tanaka; Yasuhiko Kobayashi; Masaaki Ryomoto; Yoshiteru Yoshioka; Yuji Miyamoto
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

4.  Second generation of minimal invasive extracorporeal circuit: pilot study resting heart system.

Authors:  George Fayad; Thomas Modine; Ghassan Naja; Benoit Larrue; Richard Azzaoui; Francis Crépin; Christophe Decoene; Lots Benhamed; Mohamed Koussa; Terence Gourlay; Henry Warembourg
Journal:  J Extra Corpor Technol       Date:  2005-12

Review 5.  Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm.

Authors:  Leen Vercaemst
Journal:  J Extra Corpor Technol       Date:  2008-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.